Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Childhood Brain Neoplasm 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Neurodegenerative Diseases 1Ischemic Stroke 1Hypoxia 1Hemorrhagic Stroke 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Central Nervous System Vascular Malformations 1Central Nervous System Infections 1Brain Neoplasms 1Brain Injuries 1

Interventions

pembrolizumab 4Oncolytic Virotherapy 4Cisplatin 4Cetuximab 3Radiotherapy 2Positron Emission Tomography Computed Tomography 2Nivolumab 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Fluorouracil 2Erlotinib Hydrochloride 2Docetaxel 2technetium 99m ethylenedicysteine deoxyglucose 1ruxolitinib 1dornase alfa 1avelumab 1alovudine 1Varenicline 1VTX-2337 1Tobacco Use Cessation Devices 1Tetrahydrouridine 1TAK-981 1Ropivacaine 1Raltegravir Potassium 1Pyrimethamine 1Postmortem Imaging 1Positron-Emission Tomography 1Paclitaxel 1Oxycodone 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Head and Neck Neoplasms × Ferrosoferric Oxide × Clear all
NCT01895829 2021-09-21

Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
7 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡